Beta-Arteether
Added to RFQ
For Research & Analytical Purposes. Not for Personal use.
Packaging & Handling
Indicative product packaging is shown for visual reference. Actual packaging may vary based on pack size, quantity, storage condition and shipping requirements.
Documentation Available
Detailed specifications, certificates, and supporting documents are available upon request.
Detailed specifications, certificates, and supporting documents are available upon request.
Storage: Refer MSDS for complete information.
Hazard: Refer MSDS for accurate information.
Beta-Arteether Product Information
Beta-Arteether is listed under API and is intended for analytical research, quality control and pharmaceutical reference standard applications. It is associated with Arteether. The product is supplied by Clearsynth under CAT No. CS-O-00947.
Clearsynth provides this compound for research and analytical use, with product information including CAS number, molecular formula, molecular weight and product enquiry details.
Technical Data
Product Name
Beta-Arteether
CAS No.
75887-54-6
CAT No.
CS-O-00947
HSN Code
38229010
Country of Origin
Can be shipped from India, Canada and USA
Molecular Formula
C17H28O5
Molecular Weight
312.40
Category
API Family
Storage Condition
Refer MSDS for complete information.
Hazard Compound
Refer MSDS for accurate information.
Description
Regulatory Description
Beta-Arteether is supplied with detailed characterization data compliant with regulatory guideline. Beta-Arteether can be used for analytical method development, method validation (AMV), Quality Control (QC) application for Abbreviated New Drug Application (ANDA), or during commercial production of Arteether.
Overview
Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and ma
Synonyms
Beta-Arteether
Application Notes
Artemether is an antimalarial agent used to treat acute uncomplicated malaria. It is administered in combination with lumefantrine for improved efficacy. This combination therapy exerts its effects against the erythrocytic stages of Plasmodium spp. and ma
Product Applications & Regulatory Search Terms
Useful product, supplier and regulatory search terms for this reference standard.